Ocugen (OCGN) Cash from Investing Activities Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -26.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.03% |
| Dec 31, 2025 | 86.82% |
| Sep 30, 2025 | -1.19% |
| Jun 30, 2025 | 59.91% |
| Mar 31, 2025 | 22.95% |
| Dec 31, 2024 | 59.24% |
| Sep 30, 2024 | -13.15% |
| Jun 30, 2024 | 20.29% |
| Mar 31, 2024 | -108.10% |
| Dec 31, 2023 | -121.35% |
| Sep 30, 2023 | -434.80% |
| Jun 30, 2023 | 570.33% |
| Mar 31, 2023 | 306.00% |
| Dec 31, 2022 | -801.59% |
| Sep 30, 2022 | 66.48% |
| Jun 30, 2022 | -124.03% |
| Mar 31, 2022 | -176.22% |
| Sep 30, 2021 | -30.04% |
| Jun 30, 2021 | 11.85% |
| Mar 31, 2021 | 9.75% |
| Dec 31, 2020 | -32.69% |
| Sep 30, 2020 | -26.07% |
| Jun 30, 2020 | 35.72% |
| Mar 31, 2020 | 81.25% |
| Dec 31, 2019 | -90.90% |
| Sep 30, 2019 | -802.33% |
| Jun 30, 2019 | 24.47% |
| Mar 31, 2019 | 30.85% |
| Sep 30, 2018 | 76.81% |
| Jun 30, 2018 | -53.99% |
| Mar 31, 2018 | 27.07% |
| Dec 31, 2017 | 34.41% |
| Sep 30, 2017 | 85.76% |
| Jun 30, 2017 | 19.56% |
| Mar 31, 2017 | -306.21% |